Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01222832 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge
A Phase 2 study, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Completed
- Registry status
- Phase 2
- Development phase
- 226
- Enrollment target
NCT01222832 is a Phase 2 study that has completed, run by Steward St. Elizabeth's Medical Center of Boston. The registered enrollment target is 226 participants.
The verdict
NCT01222832, a Phase 2 study, has completed, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 226 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of a nasopore sponge dressing soaked in Bacitracin VS a sponge soaked in Saline / and the administration of oral antibiotics.
Interventions
- DRUG Bacitracin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01222832
The ClinicalTrials.gov registry entry for NCT01222832 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Steward St. Elizabeth's Medical Center of Boston, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bacitracin is the first listed.
NCT01222832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01222832 about?
NCT01222832 is a clinical study titled "Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge". This study will evaluate the efficacy of a nasopore sponge dressing soaked in Bacitracin VS a sponge soaked in Saline / and the administration of oral antibiotics.
What is the current status of trial NCT01222832?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 226 participants. The study started on 2010-07. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01222832?
The interventions under investigation include: Bacitracin (DRUG).
Who is sponsoring clinical trial NCT01222832?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.